Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraluminal cefotaxime for prevention of systemic infection in permanent hemodialysis catheter
IRCT138811182370N6Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cefotaxime in end-stage kidney disease (ESKD) and catheter-associated bloodstream infection (CRBSI), sponsored by Isfahan University of Medical Sciences. Started Sep 2009; status: completed.
02
Drugs
cefotaxime
03
Conditions
end-stage kidney disease (ESKD)catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on IRCT138811182370N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138811182370N6.